Feature | March 27, 2013

Biotronik Iforia is World’s First DF4 ICD/CRT-D Approved for MRI

First implantations of the device taking place worldwide

Biotronik Iforia ICD/CRT-D CE-Approval

March 27, 2013 — Biotronik received CE mark for its most advanced ICD/CRT-D (implantable cardioverter defibrillator/cardiac resynchronization therapy device) series. Iforia is the world’s first DF4 ICD/CRT-D series approved for MRI (magnetic resonance imaging). In addition it contains one of the world’s smallest ICDs, the Iforia single chamber ICD.

Aside from featuring ProMRI technology, which allows patients to undergo potentially life-saving MRI scans, Iforia also includes the industry standard DF4 connector system, which is designed to simplify and shorten the implantation procedure. The DF4 connector combines the traditional three connectors into one, allowing for a more convenient implantation procedure without compromising safety.

One of the first implanters, Ching Chi Keong, M.D., of National Heart Centre Singapore, said, “With the Iforia series I can provide my patients with a small and highly reliable ICD and CRT-D series. It includes an impressive range of state-of-the-art innovations including ProMRI and home monitoring. In addition the DF4 technology simplifies the implantation procedure, while the small size of the device makes it more comfortable for the patient and also leads to a better cosmetic result.”

The Iforia series is one of the smallest ICDs and CRT-Ds on the market. In addition the Iforia single chamber ICD has a longevity of more than 11 years and the Iforia CRT-D of more than seven years. This allows for a low replacement rate, benefitting both patients and the healthcare system.

“Safety and reliability are the foundation of all of our new technologies and innovations,” said Christoph Böhmer, president international of Biotronik. “Iforia offers enhanced diagnostic possibilities with the highest reliability and unsurpassed longevity... The new Iforia series combined with ProMRI and Biotronik Home Monitoring offers physicians and patients the best combination of reliability and innovation.”

The European market release of the Iforia series is expected in mid-2013. The first implanters of Biotronik's Iforia ICDs and CRT-Ds are:

  • Prof. Dr. Steffen Behrens, Vivantes Humboldt Hospital Berlin, Germany;
  • Ching Chi Keong, M.D., National Heart Centre Singapore, Singapore;
  • Dr. Thomas Faber, University Heart Centre Freiburg, Germany;
  • Prof. Dr. Stephan B. Felix and Dr. Mathias Busch, University Hospital Greifswald, Germany;
  • Dr. Peter Lercher and Dr. Günther Prenner, LKH-University Clinic Graz, Austria;
  • Abdulmohsen al Musaad, M.D., National Guard Health Affairs Hospital, Riyadh, Saudi Arabia;
  • Dr. Antti Ylitalo and Dr. Tuomas Paana, Satakunta Central Hospital, Pori, Finland.


For more information: www.biotronik.com

Related Content

Trial Data Shows Positive Predictive Results for Boston Scientific HeartLogic Heart Failure Diagnostic
News | Heart Failure| October 20, 2017
October 20, 2017 — Boston Scientific announced new data from the Multisensor Chronic Evaluation in Ambulatory Heart F
Smartphone Apps Help Patients and Providers Manage Atrial Fibrillation
News | Patient Engagement| October 19, 2017
October 19, 2017 — Novel smartphone and tablet applications for atrial fibrillation patients and healthcare professio
The Respicardia Remede System is a pacemaker-like device designed to improve cardiovascular health by restoring natural breathing during sleep in patients with Central sleep apnea.
Technology | Heart Failure| October 18, 2017
October 18, 2017 — The U.S.
MRI May Predict Neurological Outcomes for Cardiac Arrest Survivors
News | Sudden Cardiac Arrest| October 18, 2017
Magnetic resonance imaging (MRI)-based measurements of the functional connections in the brain can help predict long-...
Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course
News | EP Lab| October 18, 2017
Baylis Medical Co. Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at...
FDA Clears Siemens Magnetom Terra 7T MRI Device

The FDA has cleared the Siemens Magnetom Terra as the first 7T MRI system in the U.S. to gain regulatory approval.

Technology | Magnetic Resonance Imaging (MRI)| October 12, 2017
The U.S. Food and Drug Administration (FDA) cleared the first 7 Tesla (7T) magnetic resonance imaging (MRI) device,...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI)| October 11, 2017
MR Solutions took their cryogen-free preclinical multimodality magnetic resonance imaging (MRI) solutions on tour in...
CardioFocus Announces European CE Mark Approval of HeartLight Excalibur Balloon
Technology | Ablation Systems| October 10, 2017
October 10, 2017 — CardioFocus Inc. recently announced the European CE Mark approval of the HeartLight Excalibur Ball
The Apama Radiofrequency (RF) Balloon Catheter System.
News | Ablation Systems| October 02, 2017
October 2, 2017 — Boston Scientific announced a definitive agreement to acquire Apama Medical Inc., a privately-held
Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD)| September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
Overlay Init